Lars-Erik Saltin

HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.

Mannheimer Swartling Advokatbyrå AB provides legal advisory services. It specializes in corporate and business law serving various sectors such as energy, real estate, financial, automobile, health care, construction, information technology, telecommunications, media, and transportation. The company was founded on July 1, 1990 and is headquartered in Stockholm, Sweden.

Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors.

Ausam Biotechnologies, Inc. provides biophysics and physiology research and development services.

Axlon Group AB engages in the development of products and cash management solutions. The firm sells devices to create a secure and effective environment for both shops personnel and cash transportation. Its products include Axlon Note and Axlon Coin devices. The company was founded in 2002 and is headquartered in Jarfalla, Sweden.

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.

AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden.

Karlskoga Industrifastighets AB is a private company that owns and manages industrial premises and offices. The company is based in Karlskoga, Sweden. The CEO of the Swedish company is Bengt Gustafsson.

Stockholms Affärsänglar Management AB (STOAF) is a venture capital firm founded in 2008 by Ted Ingemar Elvhage, Klaus Olle Alfred Gottwald and Åke Lennart Ohlsson. The firm is headquartered In Stockholm, Sweden.

Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden.

Sustainable Energy Angels AB (SEA) is a venture capital firm founded in 2013 by Ulf Carl Fredrik Billing and Jonas Christofer Nyman. The firm is headquartered in Vasteras, Sweden.

Vanadis Diagnostics AB develops a novel solution for non-invasive prenatal testing based on digital analysis of cell-free DNA. The company was founded by Olle Ericsson and Fredrik Dahl in 2013 and is headquartered in Sollentuna, Sweden.

Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden.

Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022.

Ct Post AB provides management consulting services. The private company is based in Linköping, Sweden.

Provins is a private company based in Sweden that offers communication agency services.

Moligo Technologies AB is a Swedish company located in Solna that engages in producing ultrapure DNA. The firm was founded in 2019 by Björn Högberg, Cosimo Ducani and Simone Codeluppi. Cosimo Ducani has been the CEO since the company founding. The company says this about itself: Moligo Technologies produces long, ultra-pure, complex DNA at industrial scale using a proprietary enzymatic synthesis process to overcome the challenges of chemical methods. The company's innovative PCR-free "injection-molding" platform can be scaled to produce kilograms of DNA, enough material to enable any cell- or gene-based therapy to go from the lab through clinical trials. With a specialty in complex, ultrapure single-stranded DNA 100 percent sequence verified and more than 10,000 bases long - and at scalable volume - Moligo helps companies take safer, more effective gene-based therapeutics, vaccines, and diagnostics over the finish line and to the patient. Moligo was founded in 2019 and is privately held.

Pixelgen Technologies AB is a company that was founded in 2020 by a team of experienced innovators and entrepreneurs. The company is based in Solna, Sweden. Pixelgen has developed a DNA-based visualization technology called molecular pixelation, which analyzes cell surface proteins to gain insights into cellular activity. The Swedish company aims to deepen the understanding of biology for a healthier world with their technology. Pixelgen's products are covered by one or more claims of patents or pending patent applications. The company was founded by Johan Erik Simon Fredriksson, Alvaro Martinez Barrio, Filip Karlsson, and Fredrik Dahl, with Johan Erik Simon Fredriksson serving as the CEO since 2020.